Shanghai Labway Clinical Laboratory Co., Ltd. (301060.SZ)
CNY 8.73
(-0.46%)
CNY 8.73
(-0.46%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 374.62 Million CNY | 76.82% |
| 2022 | 211.86 Million CNY | 222.47% |
| 2021 | 65.7 Million CNY | -4.08% |
| 2020 | 68.49 Million CNY | 0.0% |
| 2019 | - CNY | -100.0% |
| 2018 | 30 Million CNY | -57.14% |
| 2017 | 70 Million CNY | -7.02% |
| 2016 | 75.28 Million CNY | 186.46% |
| 2015 | 26.28 Million CNY | 31.4% |
| 2014 | 20 Million CNY | -20.0% |
| 2013 | 25 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 291.86 Million CNY | -18.12% |
| 2024 Q2 | 350.7 Million CNY | -4.63% |
| 2024 Q1 | 367.71 Million CNY | -1.84% |
| 2023 Q1 | 216.23 Million CNY | 2.07% |
| 2023 FY | 374.62 Million CNY | 76.82% |
| 2023 Q4 | 374.62 Million CNY | -4.7% |
| 2023 Q3 | 393.1 Million CNY | 53.25% |
| 2023 Q2 | 256.51 Million CNY | 18.62% |
| 2022 FY | 211.86 Million CNY | 222.47% |
| 2022 Q3 | 161.48 Million CNY | -2.51% |
| 2022 Q2 | 165.64 Million CNY | 167.69% |
| 2022 Q4 | 211.86 Million CNY | 31.2% |
| 2022 Q1 | 61.87 Million CNY | -5.82% |
| 2021 Q1 | - CNY | 0.0% |
| 2021 Q3 | 61.84 Million CNY | -2.68% |
| 2021 Q4 | 65.7 Million CNY | 6.24% |
| 2021 FY | 65.7 Million CNY | -4.08% |
| 2021 Q2 | 63.54 Million CNY | 0.0% |
| 2020 Q4 | - CNY | 0.0% |
| 2020 Q1 | - CNY | 0.0% |
| 2020 FY | 68.49 Million CNY | 0.0% |
| 2020 Q2 | - CNY | 0.0% |
| 2020 Q3 | - CNY | 0.0% |
| 2019 FY | - CNY | -100.0% |
| 2019 Q4 | - CNY | 0.0% |
| 2018 FY | 30 Million CNY | -57.14% |
| 2017 Q1 | 86.35 Million CNY | 14.7% |
| 2017 Q2 | 86.35 Million CNY | 0.0% |
| 2017 FY | 70 Million CNY | -7.02% |
| 2016 Q1 | 104.7 Million CNY | 298.4% |
| 2016 Q2 | 104.7 Million CNY | 0.0% |
| 2016 FY | 75.28 Million CNY | 186.46% |
| 2016 Q3 | 75.28 Million CNY | -28.1% |
| 2016 Q4 | 75.28 Million CNY | 0.0% |
| 2015 Q4 | 26.28 Million CNY | 0.0% |
| 2015 Q3 | 26.28 Million CNY | 0.0% |
| 2015 Q1 | - CNY | 0.0% |
| 2015 FY | 26.28 Million CNY | 31.4% |
| 2014 FY | 20 Million CNY | -20.0% |
| 2013 FY | 25 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Dian Diagnostics Group Co.,Ltd. | 4.29 Billion CNY | 91.271% |
| Hangzhou Tigermed Consulting Co., Ltd. | 3.34 Billion CNY | 88.806% |
| Dirui Industrial Co.,Ltd. | 714.1 Million CNY | 47.54% |
| Beijing Strong Biotechnologies, Inc. | 1.13 Billion CNY | 67.012% |
| Medicalsystem Biotechnology Co., Ltd. | 108.17 Million CNY | -246.323% |
| Maccura Biotechnology Co.Ltd | 665.16 Million CNY | 43.68% |
| Guangzhou Wondfo Biotech Co.,Ltd | 599.53 Million CNY | 37.515% |
| Guangdong Hybribio Biotech Co.,Ltd. | 56.65 Million CNY | -561.264% |
| BGI Genomics Co., Ltd. | 1.09 Billion CNY | 65.832% |
| Amoy Diagnostics Co., Ltd. | 108.34 Million CNY | -245.764% |